Alphadyne Asset Management »

Bridgebio Pharma shares owned by Alphadyne Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Alphadyne Asset Management from 13F filings

Historical chart of Alphadyne Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Alphadyne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Alphadyne Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 14k 74.26

More positions owned by Alphadyne Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Exxon Mobil Corporation Call Option (XOM)
Johnson & Johnson Call Option (JNJ)
FedEx Corporation (FDX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)
Meta Platforms Cl A (META)
CF Industries Holdings (CF)
Merck & Co Call Option (MRK)
Alphabet Cap Stk Cl A (GOOGL)
Target Corporation Call Option (TGT)
Raytheon Technologies Corp (RTX)
NVIDIA Corporation (NVDA)
Amgen (AMGN)

View all positions for Alphadyne Asset Management

Top funds holding Bridgebio Pharma

BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
Jane Street
State Street Corporation
Geode Capital Management
Invesco
Susquehanna International
Frazier Life Sciences Management

View all funds holding Bridgebio Pharma